Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

InDex Pharmaceuticals Holding AB (INDEX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.3550 -0.0020    -0.56%
09:53:58 - Real-time Data. Currency in SEK ( Disclaimer )
Type:  Equity
Market:  Sweden
ISIN:  SE0008966295 
S/N:  532687650
  • Volume: 286,380
  • Bid/Ask: 0.3500 / 0.3550
  • Day's Range: 0.3480 - 0.3600
InDex Pharma 0.3550 -0.0020 -0.56%

InDex Pharmaceuticals Holding AB Company Profile

 
Get an in-depth profile of InDex Pharmaceuticals Holding AB, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

6

Equity Type

ORD

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company’s lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences for the treatment of various immunological diseases. InDex Pharmaceuticals Holding AB (publ) was founded in 2000 and is headquartered in Solna, Sweden.

Contact Information

Address Berzelius väg 13
Solna, 171 65
Sweden
Phone 46 8 12 20 38 50
Fax -

Top Executives

Name Age Since Title
Jonas Halfvarson - - Member of Advisory Board - Europe
Wenche Rolfsen 71 2011 Independent Chairman
Raja Atreya - - Member of Advisory Board - Europe
Uli Hacksell 73 2016 Independent Director
Laurent Peyrin-Biroulet - 2022 Chairman of Advisory Board - Europe
David T. Rubin - - Member of Advisory Board - North America
Walter Reinisch - - Member of Advisory Board - Europe
Franco Scaldaferri - - Member of Advisory Board - Europe
Lennart Hansson 67 2011 Independent Director
Geert D’Haens - - Member of Advisory Board - Europe
Marlene Forsell 47 2020 Independent Director
Florian Rieder - - Member of Advisory Board - North America
Brian Gordon Feagan - - Member of Advisory Board - North America
Anna-Kaija Gronblad 55 2022 Independent Director
Bruce E. Sands - - Member of Advisory Board - North America
Karin Bernadotte 60 2022 Independent Director
Christina Ha - - Member of Advisory Board - North America
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INDEX Comments

Write your thoughts about InDex Pharmaceuticals Holding AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email